Buprenorphine And Naloxone
Product Images NDC 53217-138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 53217-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride)

Chemical Structure (Buprenorphine Hydrochloride)
Chemical structure diagram of Buprenorphine and Naloxone, showing the molecular arrangement including rings, functional groups, and bonds. The structure depicts the complex chemical configuration with labeled atoms and substituents.*
FDA Label Image

Chemical Structure (Naloxone Hydrochloride Dihydrate)

Chemical Structure (Naloxone Hydrochloride Dihydrate)
Chemical structure of buprenorphine hydrochloride dihydrate, showing its molecular framework including hydroxyl, ketone, and amine functional groups, consistent with the active ingredient buprenorphine in Buprenorphine and Naloxone by Aidarex Pharmaceuticals LLC.*
FDA Label Image

Figure 3 (Buprenorphine Naxalone 3)

Figure 3 (Buprenorphine Naxalone 3)
An instructional black-and-white illustration showing a person's open mouth with the tongue lifted, demonstrating the placement of a small circular film or tablet on the mucosa under the tongue or inside the mouth using a finger.*
FDA Label Image

Packaged Label (Buprenorphine Naxalone 4)

Packaged Label (Buprenorphine Naxalone 4)
Buprenorphine and Naloxone sublingual tablets, 8 mg / 2 mg strength, packaged as 30 tablets. The label prominently shows the active ingredients and states the product is generic for Suboxen. Manufactured by Ethypharma S.A. in France and labeled by Aidarex Pharmaceuticals LLC. The label includes NDC 53217-0138-30 and cautions about federal law on drug transfer. It features dosage instructions in English and Spanish and various lot and RX numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.